Immortalized canine dystrophic myoblast cell lines for development of peptide-conjugated splice-switching oligonucleotides
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disease caused by frameshift or nonsense mutations in the <i>DMD</i> gene, resulting in the loss of dystrophin from muscle membranes. Exon skipping using splice-switching oligonucleotides (SSOs) restores the reading frame of &l...
Huvudupphovsmän: | Tone, Y, Mamchaoui, K, Tsoumpra, MK, Hashimoto, Y, Terada, R, Maruyama, R, Gait, MJ, Arzumanov, AA, McClorey, G, Imamura, M, Takeda, S, Yokota, T, Wood, MJA, Mouly, V, Aoki, Y |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Mary Ann Liebert
2021
|
Liknande verk
Liknande verk
-
Cell-penetrating peptide conjugates of steric blocking oligonucleotides as therapeutics for neuromuscular diseases from a historical perspective to current prospects of treatment
av: Gait, M, et al.
Publicerad: (2018) -
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
av: James S. Novak, et al.
Publicerad: (2017-10-01) -
Cell-penetrating peptides to enhance delivery of Oligonucleotide-based therapeutics
av: McClorey, G, et al.
Publicerad: (2018) -
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
av: James S. Novak, et al.
Publicerad: (2018-03-01) -
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
av: James S. Novak, et al.
Publicerad: (2018-01-01)